January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Wafik S. El-Deiry: Honored to express a vision for the field of cancer research and innovation in oncology
Jan 18, 2025, 22:58

Wafik S. El-Deiry: Honored to express a vision for the field of cancer research and innovation in oncology

Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center shared a post on LinkedIn:

“Cancer affects us all in some way. Change is coming after a brief period of great leadership by Dr. Kimryn Rathmell. Whatever happens, it is an honor to express a vision for the field of cancer research and innovation in oncology.

Research on causes and cures brings hope for patients.”

Wafik S. El-Deiry-cancer research

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared Wafik S. El-Deiry’s post on LinkedIn adding:

“Congratulations Dr. Wafik S. El-Deiry, MD, PhD, FACP. The field would be blessed to have your profound leadership.

Thank you for your continued mentorship and generosity of your time to the future of medicine and science.”

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.

Yan Leyfman MD, is the Co-founder and executive director of MedNews Week. He is also the Medical correspondent at OncLive. He is the Executive Committee Member at Music Beats Cancer.

He is a Clinical Researcher at Icahn School of Medicine at Mount Sinai. His research interests include oncology, Immuno Oncology, Cellular Therapy, and Immunotherapy.

More posts featuring Wafik S. El-Deiry and Yan Leyfman.